SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals. (Q34063645)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals. |
scientific article |
Statements
SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals (English)
Sophie Bouyon
Véronique Roussel
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference